Decrease in Smoking Rates Correlates with Fewer Cases of Gastroschisis in Newborns

A decline in maternal smoking in the U.S. has been linked to a decrease in the number of newborns with gastroschisis, highlighting the impact of public health efforts on congenital birth defects.
Recent research presented at the American Academy of Pediatrics 2025 National Conference and Exhibition reveals a significant link between declining smoking rates in the U.S. population and a reduction in infants born with gastroschisis, a congenital birth defect where organs develop outside the body due to incomplete abdominal wall formation. Over the past few years, public health initiatives aimed at discouraging smoking, especially among women of reproductive age, have contributed to a steady decrease in maternal smoking prior to conception. This decline appears to be directly associated with a drop in gastroschisis cases.
Analyzing data from the U.S. Department of Health and Human Services covering 2017 to 2023, researchers identified 5,121 newborns diagnosed with gastroschisis out of over 25 million live births. Notably, 16.75% of these cases involved mothers with a history of smoking before pregnancy. Maternal smoking rates decreased from 9.4% in 2017 to 4.1% in 2023. During this same period, the incidence of gastroschisis also fell from 2.4 to 1.6 cases per 10,000 births.
The study also found that for each additional 10 cigarettes smoked daily before pregnancy, the risk of a gastroschisis diagnosis increased by 39%. Experts emphasize that public health efforts targeting smoking cessation can have far-reaching effects beyond general health, notably reducing the prevalence of rare congenital conditions. Dr. Zane Hellmann highlighted that addressing common risk factors like smoking can significantly impact the occurrence of complex birth defects, demonstrating the importance of preventive healthcare strategies.
This research underscores the importance of continued public health campaigns against smoking, emphasizing their role in improving birth outcomes and reducing the prevalence of congenital abnormalities in future generations.
Source: Medical Xpress
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative AI-Powered ECG Tool Shows Promise for Early Heart Failure Detection in Kenya
A groundbreaking AI-powered ECG algorithm shows high accuracy in early detection of heart failure in Kenya, offering a scalable solution for resource-limited healthcare settings.
Breakthrough in Muscle Regeneration: Identifying the 'Control Center' to Improve Elderly Muscle Healing
A groundbreaking study reveals a cellular 'control center' in muscle tissue that could revolutionize treatments for age-related muscle loss and improve healing in the elderly through new cellular communication pathways.
The Challenges of Medication Use During Pregnancy in the Context of Reduced Medical Research Funding
Pregnant women often lack sufficient safety data on medications due to persistent underfunding and ethical barriers, risking maternal and fetal health. Learn how research cuts threaten progress in this critical area.
Discovery of Heparanase 2: The Natural Protector of Blood Vessel Integrity
Researchers have identified heparanase 2 as a natural molecule that safeguards blood vessel integrity, opening new possibilities for vascular disease treatments. Discover how Hpa2 maintains vessel stability and may revolutionize therapies for related conditions.